Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol - Wikidata - awgldk - TriplyDB

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol

http://www.wikidata.org/entity/Q37031038

about

Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement Inflammatory response in islet transplantation.Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures.Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop.Assessment of β-cell mass and α- and β-cell survival and function by arginine stimulation in human autologous islet recipients.Pancreatic ductal perfusion at organ procurement enhances islet yield in human islet isolation.Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 Diabetes Islet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes?Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop.Successful Application of Closed-Loop Artificial Pancreas Therapy After Islet Autotransplantation.Puzzling about partial glucagon responses to hypoglycemia in intrahepatic islet recipients: missing pieces.Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.Minimizing immunosuppression in islet xenotransplantation.Clinical implementation of islet transplantation: A current assessment.Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.Islet cell transplant: Update on current clinical trials.Brief review: cell replacement therapies to treat type 1 diabetes mellitus.Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes.Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation.Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.Multicenter Assessment of Animal-free Collagenase AF-1 for Human Islet Isolation.Cost and clinical outcome of islet transplantation in Norway 2010-2015.Unmethylated Insulin DNA Is Elevated After Total Pancreatectomy With Islet Autotransplantation: Assessment of a Novel Beta Cell Marker.Loss of end-differentiated β-cell phenotype following pancreatic islet transplantation.Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes: a Consensus Report on the Igls Criteria from the IPITA/EPITA Opinion Leaders Workshop.α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.

P2860

Q26752205-F8A213DA-D367-429A-AC41-319B6765EDCB Q26769878-7C1D92E1-EFE6-4830-96CD-00EF96A52F05 Q33614652-52F74A52-D1A2-41AE-935E-637C7E2B574F Q33628076-C1834C51-27D9-4DB9-93F1-FA825130AB45 Q34383031-BED54864-F6DD-478B-885D-34EDA692A8E6 Q35004304-9D38D3A2-7E54-498A-BC69-4740D47E090D Q35410997-D8B5056C-1E85-4252-B66C-B632EE4808D3 Q35532258-88320643-A74D-4C11-AF48-EE3364580B5D Q35630705-48F6B531-1213-4D95-AF5A-6E919D5BEC49 Q35630711-49D648E9-7009-47B9-82AB-3B4AFDB14C63 Q36054574-6E76B22E-9F12-4FEB-8A35-EA20B2B340FD Q36834244-9AFDBE1B-B601-47C2-895F-8D87F2ACDAEC Q36926310-699EA0E5-BC27-4E8C-B5FC-B67630EAEC7B Q37357372-D9C71A52-36C7-44E1-8665-40AAFB5F72F2 Q38210810-65B311DA-AB87-4A49-86AE-5A0B711408AC Q38530484-948B0E3B-063E-4616-A4F8-7966369FD6D0 Q38651610-13CA1D64-5BF6-4C96-BAFA-A08A833C482F Q38689971-C3A567DA-C084-4DD4-BC51-0B8AE1C61CC2 Q39431694-803302AB-7ED5-43AA-9ADA-A93A0F4C93EC Q39444068-C6E1C01B-95EB-4ED8-9E86-2E12B2143011 Q40955221-D7E924C4-6437-44F0-935E-C821581CB664 Q47155255-FA87F50C-CA4E-45CC-B068-3F93F9D9F5A3 Q47292885-7096C436-B269-4877-8FAB-E936F332A579 Q47628461-4ED3E4F3-9EB8-43F7-B6A6-442774AB7E31 Q48282844-474D779D-8BD5-4D67-A674-C93722209406 Q49832092-71C40BB9-E1DF-4F27-A605-024603652AE9 Q49906467-776C2932-FA1A-4E84-8E6A-9A055DB11E04 Q51204217-A88D3DB2-87AB-499D-A4DC-A8F210414CD7

P2860

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol

http://www.wikidata.org/entity/Q37031038

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improvement in β-cell secretor ...... ccording to the CIT07 protocol

@en

Improvement in β-cell secretor ...... cording to the CIT07 protocol.

@nl

type

label

Improvement in β-cell secretor ...... ccording to the CIT07 protocol

@en

Improvement in β-cell secretor ...... cording to the CIT07 protocol.

@nl

prefLabel

Improvement in β-cell secretor ...... ccording to the CIT07 protocol

@en

Improvement in β-cell secretor ...... cording to the CIT07 protocol.

@nl

P1433

Q37031038-3AC796CC-DAB5-4A0A-90E2-B7AD247D4A48

P1476

Q37031038-CA8B6A62-5FBA-455B-9573-24D1398C6A92

P2093

Q37031038-080D7D1C-0683-4B3F-A0DE-FB8884886D49

Q37031038-193D2409-8845-4ECC-B3CA-A8943CFDE438

Q37031038-1A7A00B0-EC80-4A2F-8079-B4C3A9975730

Q37031038-26030ED9-27E1-4EBC-9904-4813ACD767C9

Q37031038-3256A65A-F3A2-496C-80F3-7C077239327A

Q37031038-3291C2CE-4984-4B20-BA85-7C98939647CB

Q37031038-388E0F5A-4BC0-44B1-AEE8-B392A0DA9F64

Q37031038-78D435E0-D01B-496C-BE6B-7D3EB6983EC6

Q37031038-798219AB-C118-40FB-8F2B-B506A3ED8134

Q37031038-83473DD0-D655-447C-8351-F554A3A12A24

P2860

Q37031038-01ABB9E0-407F-47BA-A8D5-33AA1E36C6D4

Q37031038-050B42C9-BCBA-4A43-9055-74D47C0DBAC7

Q37031038-0C3D4979-ABEF-4047-A782-D31519DF1D25

Q37031038-29E63C4A-0913-45BA-AAF0-E0B0D88C5505

Q37031038-2FE7FD18-5B28-450D-A1FB-511A1B46E36D

Q37031038-346D3F3A-4CE7-425C-8E25-809BB57590CA

Q37031038-43AF1B06-4678-4329-864B-EAC003C656EC

Q37031038-4531E4DA-DCB9-48F6-A6C6-5325BBD8C00F

Q37031038-47E9B8E4-2860-4E94-9C24-683250115D3E

Q37031038-4E572D16-8BDE-4545-AE25-91677BB50B06

P304

Q37031038-110E9FEB-2980-4B7B-A579-FFBD539E9C04

P31

Q37031038-E27DF37D-4817-4A1D-867E-9188A86878CE

P356

Q37031038-A9A1026F-F848-4A71-B1C4-6842B510FB1F

P407

Q37031038-A679F01B-45D6-4328-B911-0F466B0E0F95

P433

Q37031038-6CC7DB67-85E6-416E-884B-647E7743CAB7

P478

Q37031038-F963C8C1-5A58-4CF6-8F14-3BDCEDAE8A6E

P50

Q37031038-02FA0386-8BB5-47BB-852D-6B8BE4C8AC8A

P577

Q37031038-FCB85D8F-520D-47F0-8E8B-395EAF061748

P5875

Q37031038-6BD0B98A-C8B2-4156-BF87-12B51FAB6434

P698

Q37031038-84CEB299-C541-438E-BB42-0F2ACE3F0C3E

P932

Q37031038-C8F0DBA6-B00A-41F2-BAE9-6192BB7AC7A4

P356

P1433

P1476

Improvement in β-cell secretor ...... ccording to the CIT07 protocol

@en

P2093

Ali Naji

http://www.w3.org/2001/XMLSchema#string

Allen J Chiou

http://www.w3.org/2001/XMLSchema#string

Carissa Fuller

http://www.w3.org/2001/XMLSchema#string

Chengyang Liu

http://www.w3.org/2001/XMLSchema#string

Clyde F Barker

http://www.w3.org/2001/XMLSchema#string

Cornelia Dalton-Bakes

http://www.w3.org/2001/XMLSchema#string

Eileen Markmann

http://www.w3.org/2001/XMLSchema#string

Eline T Luning Prak

http://www.w3.org/2001/XMLSchema#string

Kumar Vivek

http://www.w3.org/2001/XMLSchema#string

Malek Kamoun

http://www.w3.org/2001/XMLSchema#string

P2860

Recovery of endocrine function after islet and pancreas transplantation

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

HLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry

Improvement in outcomes of clinical islet transplantation: 1999-2010.

Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.

{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants

Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.

Hypersensitivity to rabbit antithymocyte globulin in an islet transplant recipient: a case report

Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes

P304

2890-2897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB12-1802

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Richard D Shlansky-Goldberg

P577

2013-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236581809

http://www.w3.org/2001/XMLSchema#string

P698

23630300

http://www.w3.org/2001/XMLSchema#string

P932

3717864

http://www.w3.org/2001/XMLSchema#string